Aprepitant Versus Dexamethasone to Prevent Delayed Emesis After Chemotherapy
- 10 July 2014
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (20) , 2184-2185
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind StudyJournal of Clinical Oncology, 2014
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2011
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conferenceAnnals of Oncology, 2010